CCNE1 and neoplasm: Because many of the substrates that FBXW7 targets for degradation are well-known oncoproteins, such as Cyclin E, c-Myc, Aurora kinase A (AURKA) and Notch-1, FBXW7 is generally accepted as a tumor suppressor [3, 4].